Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03831191

Public ClinicalTrials.gov record NCT03831191. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 4:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3375880 in Adult Subjects With Moderate-to-Severe Atopic Dermatitis: The ADmIRe Study

Study identification

NCT ID
NCT03831191
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

  • LY3375880 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 11, 2019
Primary completion
Feb 26, 2020
Completion
Feb 26, 2020
Last update posted
Apr 19, 2021

2019 – 2020

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Tien Q. Nguyen, MD inc. DBA First OC Dermatology Fountain Valley California 92708
Dermatology Research Associates Los Angeles California 90045
Quest Dermatology Research Northridge California 91324
Integrative Skin Science and Research Sacramento California 95815
Arlington Dermatology Rolling Meadows Illinois 60008
The South Bend Clinic South Bend Indiana 46617
Dermatology and Skin Cancer Specialists Rockville Maryland 20850
ActivMed Practices & Research, Inc Portsmouth New Hampshire 03801
Piedmont Plastic Surgery and Dermatology Charlotte North Carolina 28277
PMG Research of Wilmington, LLC Wilmington North Carolina 28411
Hightower Clinical Trial Services Norman Oklahoma 73072
Oregon Dermatology and Research Center Portland Oregon 97210
Clinical Partners LLC Johnston Rhode Island 02919
Center for Clinical Studies Houston Texas 77004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03831191, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2021 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03831191 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →